PL349137A1 - Use of cholesterol-lowering agent - Google Patents

Use of cholesterol-lowering agent

Info

Publication number: PL349137A1
Authority: PL; Poland
Prior art keywords: cholesterol; lowering agent; lowering; agent
Prior art date: 1999-02-06

Application number

PL00349137A

Other languages

English (en)

Inventor

Ali Raza

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-02-06

Filing date

2000-02-01

Publication date

2002-07-01

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26315084&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL349137(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-02-06 Priority claimed from GBGB9902590.0A external-priority patent/GB9902590D0/en

1999-09-08 Priority claimed from GBGB9921062.7A external-priority patent/GB9921062D0/en

2000-02-01 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2002-07-01 Publication of PL349137A1 publication Critical patent/PL349137A1/xx

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Steroid Compounds (AREA)

PL00349137A 1999-02-06 2000-02-01 Use of cholesterol-lowering agent PL349137A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9902590.0A GB9902590D0 (en)	1999-02-06	1999-02-06	Use of cholesterol-lowering agent
GBGB9921062.7A GB9921062D0 (en)	1999-09-08	1999-09-08	Use of cholestrol-lowering agent

Publications (1)

Publication Number	Publication Date
PL349137A1 true PL349137A1 (en)	2002-07-01

Family

ID=26315084

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL00349137A PL349137A1 (en)	1999-02-06	2000-02-01	Use of cholesterol-lowering agent

Country Status (22)

Country	Link
EP (1)	EP1150679A1 (id)
JP (2)	JP2002536333A (id)
KR (1)	KR100699287B1 (id)
CN (1)	CN1347320A (id)
AR (1)	AR022462A1 (id)
AU (1)	AU769897B2 (id)
BR (1)	BR0007991A (id)
CA (1)	CA2358641A1 (id)
CZ (1)	CZ20012631A3 (id)
EE (1)	EE04659B1 (id)
HK (1)	HK1040924A1 (id)
HU (1)	HUP0105019A3 (id)
ID (1)	ID30131A (id)
IL (1)	IL144662A0 (id)
IS (1)	IS5996A (id)
MY (1)	MY136382A (id)
NO (1)	NO319827B1 (id)
NZ (1)	NZ512681A (id)
PL (1)	PL349137A1 (id)
SK (1)	SK11112001A3 (id)
TR (1)	TR200102236T2 (id)
WO (1)	WO2000045819A1 (id)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0001621D0 (en)	2000-01-26	2000-03-15	Astrazeneca Ab	Pharmaceutical compositions
GB0003305D0 (en)	2000-02-15	2000-04-05	Zeneca Ltd	Pyrimidine derivatives
SE0103509D0 (sv) *	2001-10-19	2001-10-19	Astrazeneca Ab	Rosuvastatin in pre demented states
GB0322552D0 (en)	2003-09-26	2003-10-29	Astrazeneca Uk Ltd	Therapeutic treatment
WO2007142581A1 (en) *	2006-06-07	2007-12-13	Astrazeneca Ab	Combination product for the treatment or prevention of dyslipidaemia
CA2689525A1 (en) *	2007-06-20	2008-12-24	Merck Sharp & Dohme Corp.	Cetp inhibitors derived from benzoxazole arylamides
CA2689575A1 (en)	2007-06-20	2008-12-24	Merck Sharp & Dohme Corp.	Cetp inhibitors derived from benzoxazole arylamides
JP2010530417A (ja) *	2007-06-20	2010-09-09	メルク・シャープ・エンド・ドーム・コーポレイション	ベンゾオキサゾールアリールアミドから誘導されたｃｅｔｐ阻害剤
EP2216095A1 (en) *	2009-01-27	2010-08-11	Koninklijke Philips Electronics N.V.	Microfluidic device for full blood count

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5260446A (en) *	1989-12-22	1993-11-09	Basf Aktiengesellschaft	Aminothiazoles
JP2648897B2 (ja) *	1991-07-01	1997-09-03	塩野義製薬株式会社	ピリミジン誘導体

2000
- 2000-01-31 AR ARP000100408A patent/AR022462A1/es unknown
- 2000-02-01 AU AU23051/00A patent/AU769897B2/en not_active Revoked
- 2000-02-01 IL IL14466200A patent/IL144662A0/xx unknown
- 2000-02-01 CZ CZ20012631A patent/CZ20012631A3/cs unknown
- 2000-02-01 NZ NZ512681A patent/NZ512681A/en not_active IP Right Cessation
- 2000-02-01 EP EP00901748A patent/EP1150679A1/en not_active Withdrawn
- 2000-02-01 KR KR1020017009822A patent/KR100699287B1/ko not_active Ceased
- 2000-02-01 HU HU0105019A patent/HUP0105019A3/hu unknown
- 2000-02-01 HK HK02102713.0A patent/HK1040924A1/zh unknown
- 2000-02-01 JP JP2000596939A patent/JP2002536333A/ja not_active Withdrawn
- 2000-02-01 EE EEP200100404A patent/EE04659B1/xx not_active IP Right Cessation
- 2000-02-01 PL PL00349137A patent/PL349137A1/xx not_active Application Discontinuation
- 2000-02-01 TR TR2001/02236T patent/TR200102236T2/xx unknown
- 2000-02-01 BR BR0007991-0A patent/BR0007991A/pt not_active Application Discontinuation
- 2000-02-01 ID IDW00200101666A patent/ID30131A/id unknown
- 2000-02-01 WO PCT/GB2000/000285 patent/WO2000045819A1/en not_active Ceased
- 2000-02-01 CN CN00803519A patent/CN1347320A/zh active Pending
- 2000-02-01 SK SK1111-2001A patent/SK11112001A3/sk not_active Application Discontinuation
- 2000-02-01 CA CA002358641A patent/CA2358641A1/en not_active Abandoned
- 2000-02-04 MY MYPI20000415A patent/MY136382A/en unknown
2001
- 2001-07-10 IS IS5996A patent/IS5996A/is unknown
- 2001-08-03 NO NO20013810A patent/NO319827B1/no active IP Right Review Request
2011
- 2011-02-22 JP JP2011035406A patent/JP2011137023A/ja active Pending

Also Published As

Publication number	Publication date
CZ20012631A3 (cs)	2001-10-17
AU769897B2 (en)	2004-02-05
MY136382A (en)	2008-09-30
NO20013810L (no)	2001-10-03
HUP0105019A3 (en)	2003-02-28
JP2011137023A (ja)	2011-07-14
JP2002536333A (ja)	2002-10-29
NO20013810D0 (no)	2001-08-03
EE200100404A (et)	2002-10-15
BR0007991A (pt)	2001-11-06
EE04659B1 (et)	2006-08-15
KR20010089631A (ko)	2001-10-06
EP1150679A1 (en)	2001-11-07
NZ512681A (en)	2003-12-19
IL144662A0 (en)	2002-05-23
IS5996A (is)	2001-07-10
HUP0105019A2 (hu)	2002-05-29
KR100699287B1 (ko)	2007-03-26
ID30131A (id)	2001-11-08
NO319827B1 (no)	2005-09-19
TR200102236T2 (tr)	2001-12-21
AR022462A1 (es)	2002-09-04
CN1347320A (zh)	2002-05-01
CA2358641A1 (en)	2000-08-10
AU2305100A (en)	2000-08-25
WO2000045819A1 (en)	2000-08-10
SK11112001A3 (sk)	2002-02-05
HK1040924A1 (zh)	2002-06-28

Legal Events

Date	Code	Title	Description
2007-10-31	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)

Publication	Publication Date	Title
GB9915414D0 (en)	1999-09-01	Medical use
HUP0202477A3 (en)	2003-02-28	Use of phthalazine derivatives
IL149374A0 (en)	2002-11-10	New use and novel n-azabicyclo-amide derivatives
PL354623A1 (en)	2004-02-09	Manufacture of polyglutamate-therapeutic agent conjugates
PL355101A1 (en)	2004-04-05	Use of h1
IL139899A0 (en)	2002-02-10	Uracil compounds and use thereof
GB9900227D0 (en)	1999-02-24	Use of a composition
IL147891A0 (en)	2002-08-14	Topical use of anti-muscarnic agents
AU4298501A (en)	2001-10-15	New combination of a betablocker and a cholesterol-lowering agent
PL339848A1 (en)	2000-10-23	Therapeutic agent against hypephosphataemia
GB9907965D0 (en)	1999-06-02	Medical use
IL144662A0 (en)	2002-05-23	Use of cholesterol-lowering agent
HUP0204208A3 (en)	2003-04-28	Antipruritic agents for external use
EP1218407A4 (en)	2003-01-08	USES OF KAPPA-CONOTOXIN PVIIA
AU7402201A (en)	2001-12-03	Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments
PL350963A1 (en)	2003-02-24	Use of arylalkanoylpyridazines
GB9925379D0 (en)	1999-12-29	Medical use
AU2001275696A1 (en)	2002-02-05	Therapeutic agent
GB9902590D0 (en)	1999-03-24	Use of cholesterol-lowering agent
GB0024517D0 (en)	2000-11-22	Use of medicaments
GB9922825D0 (en)	1999-11-24	Medical use
GB9929772D0 (en)	2000-02-09	New use
GB9921062D0 (en)	1999-11-10	Use of cholestrol-lowering agent
GB9906124D0 (en)	1999-05-12	Therapeutic agent
GB9910667D0 (en)	1999-07-07	New use of citreamicins